tyrosine and eplerenone

tyrosine has been researched along with eplerenone in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colucci, WS; Kotlyar, E; Kuster, GM; Liao, R; Rude, MK; Sam, F; Siwik, DA	1
Kinouchi, T; Kitazato, KT; Nagahiro, S; Satomi, J; Shimada, K; Tada, Y; Tamura, T; Yagi, K	1
Christou, DD; English, M; Hwang, MH; Kim, HK; Luttrell, M; Meade, TH; Segal, MS; Yoo, JK	1
Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP	1

Trials

1 trial(s) available for tyrosine and eplerenone

Article	Year
Mineralocorticoid receptors modulate vascular endothelial function in human obesity. Clinical science (London, England : 1979), 2013, Volume: 125, Issue:11 Topics: Abdominal Fat; Aged; Body Composition; Body Mass Index; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Eplerenone; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Obesity; Oxidative Stress; Receptors, Mineralocorticoid; Spironolactone; Tyrosine; Ultrasonography	2013

Article

Year

Mineralocorticoid receptors modulate vascular endothelial function in human obesity.

Clinical science (London, England : 1979), 2013, Volume: 125, Issue:11

Topics: Abdominal Fat; Aged; Body Composition; Body Mass Index; Brachial Artery; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Eplerenone; F2-Isoprostanes; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Obesity; Oxidative Stress; Receptors, Mineralocorticoid; Spironolactone; Tyrosine; Ultrasonography

2013

Other Studies

3 other study(ies) available for tyrosine and eplerenone

Article	Year
Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation, 2005, Feb-01, Volume: 111, Issue:4 Topics: Animals; Aorta; Apoptosis; Blood Pressure; Cell Size; Chronic Disease; Constriction, Pathologic; Drug Evaluation, Preclinical; Eplerenone; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Intercellular Adhesion Molecule-1; Ligation; Male; Matrix Metalloproteinases; Mice; Mineralocorticoid Receptor Antagonists; Myocarditis; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pressure; Random Allocation; Receptors, Mineralocorticoid; Spironolactone; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tyrosine	2005
Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cerebral Arteries; Chemokine CCL2; Eplerenone; Female; Gene Expression; Hypertension, Renal; Immunohistochemistry; Intracranial Aneurysm; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Ovariectomy; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tyrosine	2009
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats. Clinical and experimental pharmacology & physiology, 2015, Volume: 42, Issue:11 Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine	2015